Immunogen, Inc. (IMGN) Misses Q3 Expectations
Get Alerts IMGN Hot Sheet
Price: $31.25 --0%
Revenue Growth %: -100.0%
Financial Fact:
Loss from operations: -38.84M
Today's EPS Names:
BFRI, HCTI, IMPM, More
Revenue Growth %: -100.0%
Financial Fact:
Loss from operations: -38.84M
Today's EPS Names:
BFRI, HCTI, IMPM, More
Join SI Premium – FREE
Immunogen, Inc. (NASDAQ: IMGN) reported Q3 EPS of ($0.44), $0.17 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $6.9 million versus the consensus estimate of $13.28 million.
For earnings history and earnings-related data on Immunogen, Inc. (IMGN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FreightCar America (RAIL) Misses Q4 EPS by 6c, provides guidance
- Bakkt Holdings, Inc. (BKKT) Announces Leadership Transition
- Embraer (ERJ) Tops Q4 EPS by 43c; offers guidance
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!